Cradle Raises $24M in Series A Funding to Advance AI-Driven Protein Engineering
Cradle aids scientists in developing new therapeutics and bio-based products like enzymes, antibodies, lab-grown food, and chemicals through its AI platform.
Company Name: Cradle
Location: Delft, The Netherlands and Zurich, Switzerland
Sector: Biotechnology, AI-Powered Protein Design
Funding Details: Raised $24M in Series A funding, total funding now at $33M
- Funding led by: Index Ventures, with participation from Kindred Capital
- Participation from: Angel investors including Chris Gibson and Tom Glocer
- Purpose of Investment: Accelerate growth, expand machine learning and biotech team, invest in product development and sales
Leadership: Stef van Grieken,CEO
Product: Machine learning platform for designing proteins for therapeutics and bio-based products
About: Cradle aids scientists in developing new therapeutics and bio-based products like enzymes, antibodies, lab-grown food, and chemicals through its AI platform. In the past year, the company has onboarded nine industry partners, including Johnson & Johnson Innovation, Novozymes, and Twist Bioscience, and is working on over 12 R&D projects.
Clients: Partnerships with companies in various sectors, including Johnson & Johnson Innovation, Novozymes, Twist Bioscience
